First-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors.
Ranee Mehra
No relevant relationships to disclose
D. Ross Camidge
Consultant or Advisory Role - Novartis
Sunil Sharma
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis
Enriqueta Felip
No relevant relationships to disclose
Daniel Shao-Weng Tan
Research Funding - Novartis
Johan F. Vansteenkiste
No relevant relationships to disclose
Tommaso Martino De Pas
Honoraria - Novartis
Dong-Wan Kim
No relevant relationships to disclose
Armando Santoro
No relevant relationships to disclose
Geoffrey Liu
No relevant relationships to disclose
Meredith Goldwasser
Employment or Leadership Position - Novartis
David Dai
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Marietta Radona
Employment or Leadership Position - Novartis
Anthony Boral
Employment or Leadership Position - Novartis Institutes for Biomedical Research
Stock Ownership - Novartis
Alice Tsang Shaw
Consultant or Advisory Role - ARIAD; Chugai Pharma; Daiichi Sankyo; Novartis; Pfizer